Mirum Pharmaceuticals, Inc. announced positive results from Cohort 2 of the pivotal PROGRESS study of ATEBRIOZ (zilurgisertib), an oral activin receptor-like kinase 2 (ALK2) inhibitor, in pediatric patients… read more.
Eli Lilly and Company announced positive late-breaking one-year results from the Phase 3 SHINE-2 study of Omvoh (mirikizumab-mrkz) in pediatric patients ages 6 to 17 with moderately to… read more.
New Australian research reveals that teenagers, their families and GPs are placed under increased pressure due to long waits for specialist mental healthcare, as researchers call on GPs… read more.
Fewer than 1 in 15 young people in South London estimated to have a mental health disorder may have received a diagnosis from NHS mental health services, according… read more.
GERPAC Congress 2026 highlights Dexmedetomidine diluted in 5% glucose and stored in polypropylene syringes is physicochemically stable for at least 21 days at 0.4 µg/mL and 28 days… read more.
Mirum Pharmaceuticals, Inc. announced topline results from the Phase 3 EXPAND study evaluating LIVMARLI (maralixibat) for the treatment of cholestatic pruritus in patients aged 6 months or older… read more.
Children living with sickle cell anaemia have no higher incidence of clinically diagnosed infections when treated with hydroxyurea. New research shows the efficacy and safety of hydroxyurea treatment… read more.
Sarepta Therapeutics, Inc. presented new data at the 31st Annual Congress of the World Muscle Society (WMS) that provide evidence of clinically meaningful functional benefit of ELEVIDYS (delandistrogene… read more.
Teddy bears fitted with medical devices such as gastronomy (feeding) tubes may help normalize and lessen medical anxiety in children who need the same devices, according to a… read more.
Denmark’s new respiratory syncytial virus (RSV) vaccination programme for pregnant women may have dramatically reduced the number of infants hospitalised with the virus, according to a new study… read more.
Starting in July 2029, public schools are required to start phasing out ultra-processed foods under a new California law that prohibits schools from serving foods high in sugar,… read more.
Edwards Lifesciences announced that the U.S. Food and Drug Administration (FDA) has approved the Autus Size-Adjustable Valve, a surgical pulmonary valve designed specifically for pediatric patients with congenital… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
